Refine
Year of publication
Document Type
- Article (722)
- Doctoral Thesis (115)
- Postprint (104)
- Conference Proceeding (37)
- Review (32)
- Other (27)
- Monograph/Edited Volume (2)
- Habilitation Thesis (2)
- Preprint (2)
Language
- English (1043) (remove)
Keywords
- inflammation (21)
- obesity (15)
- oxidative stress (15)
- type 2 diabetes (14)
- insulin resistance (13)
- LC-MS/MS (12)
- carotenoids (12)
- insulin (12)
- Biomarker (11)
- cancer (11)
Institute
- Institut für Ernährungswissenschaft (1043) (remove)
In cultured rat hepatocytes the key gluconeogenic enzyme phosphoenolpyruvate carboxykinase (PCK) is known to be induced by glucagon via an elevation of cAMP. Prostaglandin E₂ has been shown to antagonize the glucagon-activated cAMP formation, glycogen phosphorylase activity and glucose output in hepatocytes. It was the purpose of the current investigation to study the potential of PGE₂ to inhibit the glucagon-induced expression of PCK on the level of mRNA and enzyme activity. PCK mRNA and enzyme activity were increased by 0.1 nM glucagon to a maximum after 2 h and 4 h, respectively. This increase was completely inhibited if 10 μM PGE2 was added concomitantly with glucagon. This inhibition by PGE₂ of glucagon-induced PCK activity was abolished by pertussis toxin treatment. When added at the maximum of PCK mRNA at 2 h, PGE₂ accelerated the decay of mRNA and reduced enzyme activity. This effect was not reversed by pertussis toxin treatment. Since in liver PGE₂ is derived from Kupffer cells, which play a key role in the local inflammatory response, the present data imply that during inflammation PGE₂ may reduce the hepatic gluconeogenic capacity via a Gᵢ-linked signal chain.